ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Fortress Biotech (FBIO)
Fortress Biotech stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$1.93▲ +3.21%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Fortress Biotech in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Fortress Biotech
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Fortress Biotech a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $1.74 and $2.11; in 9 out of 10, between $1.47 and $2.50. Estimated annual volatility is 47%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $67.7M
- P/E ratio
- 0.7
- 52-week high
- $4.53
- 52-week low
- $1.83
- Revenue (12 months)
- $68.5M
- Revenue growth (YoY)
- +9.7%
- Gross margin
- 66.9%
- Operating margin
- -111.0%
- Net margin
- -52.0%
- Return on equity
- 116.0%
- Free cash flow (12 months)
- $-17.1M
- Beta
- 1.19
What this means
ATLAS does not publish a fair value for FBIO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks FBIO has traded between $1.83 and $4.53. Today it is 57.4% below that high and 5% above its low.
On the business: revenue grew 9.7% year over year; net margin is 52.0%; it trades at 0.7 times earnings.
Its beta is 1.19: it tends to move more than the market, both up and down.
About the company
Fortress Biotech, Inc. is a biopharmaceutical company focused on developing, manufacturing, and commercializing pharmaceutical and biotechnology products. Fortress Biotech operates through two core areas: dermatology product sales and pharmaceutical and biotechnology product development.
Want to see everything about Fortress Biotech?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Fortress Biotech do?
Fortress Biotech, Inc. is a biopharmaceutical company focused on developing, manufacturing, and commercializing pharmaceutical and biotechnology products. Fortress Biotech operates through two core areas: dermatology product sales and pharmaceutical and biotechnology product development.
What is the chance FBIO goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, FBIO ends the month between $1.74 and $2.11.
How big is Fortress Biotech and what is its P/E ratio?
Fortress Biotech's market capitalization is $67.7M. Its price-to-earnings (P/E) ratio is 0.7: you pay $0.7 for each $1 of yearly earnings.
How volatile is FBIO?
ATLAS estimates annual volatility at 47%. In a typical month, half of the outcomes end between $1.74 and $2.11.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer